Skip to main content
Fig. 1 | BMC Complementary and Alternative Medicine

Fig. 1

From: Antiangiogenic effects of oridonin

Fig. 1

Effect of oridonin on HUVEC viability. HUVECs were treated with various concentrations (20–2500 μg/ml) of oridonin, and viability was determined by MTT assay at 24, 48, 72, and 96 h. a HUVEC viability at 24 h; b HUVEC viability at 48 h; c HUVEC viability at 72 h; d HUVEC viability at 96 h

Back to article page

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us